Categories Cannabis, Earnings

GW Pharmaceuticals (GWPH) posts better-than-expected Q3 results

GW Pharmaceuticals (NASDAQ: GWPH) beat revenue estimates and reported a narrower-than-expected loss for the third quarter of 2019. Despite the beat, the stock tumbled 12% in aftermarket hours on Tuesday.

Total revenue was $91 million compared to $2.4 million in the prior-year period. This was above estimates of $85.3 million.

Photo Courtesy: Rex Medlen from Pixabay

Net loss was $13.8 million, or $0.04 per share, compared to a loss of $79.9 million, or $0.23 per share last year. Analysts had forecast a loss of $0.85 per share.

Epidiolex sales in the US totaled $86.1 million during the quarter. Over 15,000 patients have received Epidiolex prescriptions since launch. The company received the European Commission approval for Epidiolex in September and commercialization is underway in France and Germany.

Also read: GW Pharmaceuticals Q3 2019 Earnings Preview

GW Pharmaceuticals is exploring the use of Epidiolex in new indications such as Tuberous Sclerosis Complex and Rett Syndrome, and studies are underway in both these areas.

The company completed three positive Phase 3 trials in Europe for Sativex, which is indicated for the treatment of multiple sclerosis. The clinical program to augment existing data is expected to start in Q1 2020. GW is also planning a clinical program for additional indications for 2020-2021.  

Cash and cash equivalents at September 30, 2019 were $554.7 million.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

MCD Earnings: McDonald’s comp sales up 12.6% in Q4; profit increases

Fast-food chain McDonald’s Corporation (NYSE: MCD) on Tuesday reported an increase in adjusted earnings for the fourth quarter of 2022 when its revenues remained broadly unchanged. The company said fourth-quarter

GM Earnings: All you need to know about General Motors Q4 2022 earnings results

General Motors Co. (NYSE: GM) reported fourth quarter 2022 earnings results today. Revenue increased 28.4% year-over-year to $43.1 billion. Net income attributable to stockholders increased 14.8% to $2 billion while EPS rose 19.8%

CAT Earnings: Highlights of Caterpillar’s Q4 2022 results

Construction-equipment manufacturer Caterpillar Inc. (NYSE: CAT) reported double-digit growth in fourth-quarter revenues and adjusted earnings. Adjusted net profit increased to $3.86 per share in the December quarter from $2.69 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top